These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10212844)

  • 21. Current concepts in insulin resistance, type 2 diabetes mellitus, and the metabolic syndrome.
    Reusch JE
    Am J Cardiol; 2002 Sep; 90(5A):19G-26G. PubMed ID: 12231075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse effect of the disturbances of glycemia and insulimemia on model PC12 cells - preliminary report.
    Rorbach-Dolata A; Piwowar A
    Pediatr Endocrinol Diabetes Metab; 2017; 23(4):174-180. PubMed ID: 29574469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type 2 diabetes in children and adolescents: a review for the primary care provider.
    Hannon TS; Gungor N; Arslanian SA
    Pediatr Ann; 2006 Dec; 35(12):880-7. PubMed ID: 17236435
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hypertension in metabolic syndrome. Etiology and consequences].
    Rett K
    Fortschr Med; 1992 Dec; 110(34):642-4. PubMed ID: 1483616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Insulin resistance--a physiopathological condition with numerous sequelae: non-insulin-dependent diabetes mellitus (NIDDM), android obesity, essential hypertension, dyslipidemia and atherosclerosis].
    Pedersen O
    Ugeskr Laeger; 1992 May; 154(20):1411-8. PubMed ID: 1631967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual endothelin receptor blockade acutely improves insulin sensitivity in obese patients with insulin resistance and coronary artery disease.
    Ahlborg G; Shemyakin A; Böhm F; Gonon A; Pernow J
    Diabetes Care; 2007 Mar; 30(3):591-6. PubMed ID: 17327326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of lipids in insulin resistance and type 2 diabetes mellitus development.
    Mingrone G; Castagneto M
    Nutrition; 1999 Jan; 15(1):64-6. PubMed ID: 9918070
    [No Abstract]   [Full Text] [Related]  

  • 28. The thiazolidinediones: a new class of antidiabetic agents.
    Barnett A
    Hosp Med; 2000 Mar; 61(3):185-8. PubMed ID: 10789389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The misconstrued metabolic syndrome essential hypertension. Chronology of interdisciplinary change in attitude].
    Rett K; Wicklmayr M; Dietze G; Mehnert H
    Med Klin (Munich); 1991 Feb; 86(2):86-91. PubMed ID: 2030665
    [No Abstract]   [Full Text] [Related]  

  • 30. Gerald M. Reaven, MD: Demonstration of the central role of insulin resistance in type 2 diabetes and cardiovascular disease.
    Kraemer FB; Ginsberg HN
    Diabetes Care; 2014; 37(5):1178-81. PubMed ID: 24757223
    [No Abstract]   [Full Text] [Related]  

  • 31. The pathogenesis of NIDDM.
    Hales CN
    Diabetologia; 1994 Sep; 37 Suppl 2():S162-8. PubMed ID: 7821732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis of type 2 diabetes mellitus.
    DeFronzo RA
    Med Clin North Am; 2004 Jul; 88(4):787-835, ix. PubMed ID: 15308380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of insulin sensitivity in clinical practice and in research settings.
    Monzillo LU; Hamdy O
    Nutr Rev; 2003 Dec; 61(12):397-412. PubMed ID: 14968910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromium deficiency might contribute to insulin resistance, type 2 diabetes mellitus, dyslipidaemia, and atherosclerosis.
    Mahdi GS
    Diabet Med; 1996 Apr; 13(4):389-90. PubMed ID: 9162617
    [No Abstract]   [Full Text] [Related]  

  • 35. [Metabolic syndrome--bridge to type II diabetes].
    Häring HU
    Z Gesamte Inn Med; 1993 Mar; 48(3):108-11. PubMed ID: 8475632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromium alleviates glucose intolerance, insulin resistance, and hepatic ER stress in obese mice.
    Sreejayan N; Dong F; Kandadi MR; Yang X; Ren J
    Obesity (Silver Spring); 2008 Jun; 16(6):1331-7. PubMed ID: 18388893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for non-insulin-dependent diabetes mellitus.
    Haffner SM
    J Hypertens Suppl; 1995 Aug; 13(2):S73-6. PubMed ID: 8576792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetic dyslipidemia.
    Kreisberg RA
    Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperinsulinism and dyslipidemias as coronary heart disease risk factors in NIDDM.
    Taskinen MR
    Adv Exp Med Biol; 1993; 334():295-301. PubMed ID: 8249693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus.
    Prior JO; Quiñones MJ; Hernandez-Pampaloni M; Facta AD; Schindler TH; Sayre JW; Hsueh WA; Schelbert HR
    Circulation; 2005 May; 111(18):2291-8. PubMed ID: 15851590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.